Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,862,069
-
Total 13F shares
-
6,734,335
-
Share change
-
+10,335
-
Total reported value
-
$108,086,477
-
Price per share
-
$16.05
-
Number of holders
-
2
-
Value change
-
+$165,877
-
Number of buys
-
1
Institutional Holders of HilleVax, Inc. - Common Stock (HLVX) as of Q4 2023
As of 31 Dec 2023,
HilleVax, Inc. - Common Stock (HLVX) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,734,335 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., TAKEDA PHARMACEUTICAL CO LTD, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Deep Track Capital, LP, VR Adviser, LLC, FRANKLIN RESOURCES INC, Carlyle Group Inc., BlackRock Inc., VANGUARD GROUP INC, and T. Rowe Price Investment Management, Inc..
This page lists
69
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.